0001193125-23-277933.txt : 20231115 0001193125-23-277933.hdr.sgml : 20231115 20231115164159 ACCESSION NUMBER: 0001193125-23-277933 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20231109 ITEM INFORMATION: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing FILED AS OF DATE: 20231115 DATE AS OF CHANGE: 20231115 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Cano Health, Inc. CENTRAL INDEX KEY: 0001800682 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE [8011] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-39289 FILM NUMBER: 231411143 BUSINESS ADDRESS: STREET 1: 9725 NW 117TH AVENUE, SUITE 200 CITY: MIAMI STATE: FL ZIP: 33178 BUSINESS PHONE: 2034227700 MAIL ADDRESS: STREET 1: 9725 NW 117TH AVENUE, SUITE 200 CITY: MIAMI STATE: FL ZIP: 33178 FORMER COMPANY: FORMER CONFORMED NAME: Jaws Acquisition Corp. DATE OF NAME CHANGE: 20200121 8-K 1 d798968d8k.htm 8-K 8-K
false 0001800682 0001800682 2023-11-09 2023-11-09 0001800682 us-gaap:CommonClassAMember 2023-11-09 2023-11-09 0001800682 us-gaap:WarrantMember 2023-11-09 2023-11-09

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d)

OF THE SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): November 15, 2023 (November 9, 2023)

 

 

 

LOGO

Cano Health, Inc.

(Exact name of registrant as specified in its charter)

 

 

Commission File Number: 001-39289

 

Delaware   98-1524224
(State or other jurisdiction of
incorporation or organization)
  (IRS Employer
Identification No.)
9725 NW 117th Avenue, Miami, FL   33178
(Address of principal executive offices)   (Zip Code)

(855) 226-6633

(Registrant’s telephone number, including area code)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

 

Trading
Symbol(s)

 

Name of each exchange
on which registered

Class A common stock, $0.01 par value per share   CANO   The New York Stock Exchange
Warrants to purchase one share of Class A common stock, each at an exercise price of $1,150.00 per share   CANO/WS   The New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company  

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐

 

 

 


Item 3.01

Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.

On November 9, 2023, the New York Stock Exchange (the “NYSE”) notified Cano Health, Inc. (the “Company”) that the NYSE had determined to (a) commence proceedings to delist the Company’s warrants, each whole warrant exercisable for one share of the Company’s Class A common stock, par value $0.01 per share (“Class A Common Stock”), at an exercise price of $1,150 per share, and listed to trade on the NYSE under the symbol “CANO/WS” (the “Warrants”) and (b) immediately suspend trading in the Warrants due to “abnormally low” price levels pursuant to Section 802.01D of the NYSE Listed Company Manual. On November 13, 2023, the NYSE issued a press release regarding such matter and filed Form 25 with the Securities and Exchange Commission to initiate delisting of the Warrants. The Company does not intend to appeal the NYSE’s determination.

Trading in the Company’s Class A Common Stock will be unaffected and will continue on the NYSE under the symbol “CANO.” Trading of the Warrants is expected to continue on the OTC market.


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

      CANO HEALTH, INC.
November 15, 2023     By:  

/s/ Mark Kent

      Mark Kent
      Chief Executive Officer
EX-101.SCH 2 cano-20231109.xsd XBRL TAXONOMY EXTENSION SCHEMA 100000 - Document - Document and Entity Information link:calculationLink link:presentationLink link:definitionLink EX-101.DEF 3 cano-20231109_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 4 cano-20231109_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Cover [Abstract] Cover [Abstract] Amendment Flag Amendment Flag Entity Central Index Key Entity Central Index Key Document Type Document Type Document Period End Date Document Period End Date Entity Registrant Name Entity Registrant Name Entity File Number Entity File Number Entity Incorporation State Country Code Entity Incorporation State Country Code Entity Tax Identification Number Entity Tax Identification Number Entity Address, Address Line One Entity Address, Address Line One Entity Address, City or Town Entity Address, City or Town Entity Address, State or Province Entity Address, State or Province Entity Address, Postal Zip Code Entity Address, Postal Zip Code City Area Code City Area Code Local Phone Number Local Phone Number Written Communications Written Communications Soliciting Material Soliciting Material Pre Commencement Tender Offer Pre Commencement Tender Offer Pre Commencement Issuer Tender Offer Pre Commencement Issuer Tender Offer Security 12b Title Security 12b Title Trading Symbol Trading Symbol Security Exchange Name Security Exchange Name Entity Emerging Growth Company Entity Emerging Growth Company Document And Entity Information [Table] Document And Entity Information [Table] Document And Entity Information [Line Items] Document And Entity Information [Line Items] Class of Stock [Axis] Class of Stock [Axis] Class of Stock [Domain] Class of Stock [Domain] Common Class A [Member] Common Class A [Member] Warrant [Member] Warrant [Member] EX-101.PRE 5 cano-20231109_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE GRAPHIC 6 g798968g1115231804429.jpg GRAPHIC begin 644 g798968g1115231804429.jpg M_]C_X 02D9)1@ ! 0$ 8 !@ #_VP!# @&!@<&!0@'!P<)"0@*#!0-# L+ M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7& MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$ P$! 0$! M 0$! 0 $" P0%!@<("0H+_\0 M1$ @$"! 0#! <%! 0 0)W $" M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$ MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4 MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,! (1 Q$ /P#W^BBDH #T MYJ"VN[>[1GMYDE57*$H<@,.HK@OB+XW_ +*@?2=.D_TV08DD4_ZI3_4UQOPY M\23:/JASU'OS73]6DJ#K2V.&>-A&JJ9[M144$T=Q"LL3!D89 M!'<5+7*GV.Y:BT4E&13 6BDI: "BDHH 6BDHH 6BDS1F@!:*2EH **2B@!:* M2C- "T4E+0 44GXT4 !KD?'/C"+PUI_EPD-J$P/E)_=']XUUU?.OCNZEN?&F MI&4D^7+Y:@]E7@5V8&@JU6TMD<6.KNE3O'J8$\\MS<23S.TDLC;G9CDDFNCT M'3IK6-KF>-D,JCRPPQE>N?QI_P /]$L]<\2+#>N/*B3S1$?^6A!Z?2O6O%^F MV;:5YYVQ20@*F.,CTK7.Z[5%T8:=SRL/AI3@ZK9A>%?$)T^86ERV;=S\I/\ M ?\ "O1 P*Y!R*\4KU?PY*\_A^U>3);9C)] 2!_*OG<#6X\2>,KG1;:=X-/L%SXMKR)"Z%)"=Y M S@COFN;\ AH?''BF"48E,Q89]-[?XBO1+FXCM+66YE.(XD+N?8#)KV:WN34 M8^1M1]^#E(JP:A'#IEI->S+%))&I._@EB.1CUJ:#4+2Y1VAN$D$?W\'E?J.U M[R*MY"3&-SC>/E'3FI+/4;/4%8VMQ',%.&V-G!] MZX+P[90S_$[Q$\BAEB"[5(XR<2:]\.)?74\TUPTCH6D>%#'D_XTZWN[>[C\RWF25O M/].O;[4/B-K3+ D_V5!#$DC8"+GDCZX_6KL.EWVE:SJ^KWLL5II=S;GS8XW^ MXP &X>_7\ZP=%+1O4W5=O5+0ZIM9TY7VF]A'S;<[N,^F>F:YOXD7$]GX;^VV MEQ+#,)44-&Y'!-8=ZL8^%]PFGVK_ &)4+I<7! =\OG=CZT_Q7(\OPCTUW)9F M2W))[\"M*=)*2?G8RJ5G*+7E2JMS>+&_ER':RYP1BJWC2-/[3\'':I+7:!N.O*5)\3(59-!A3 MY UZ -O&,XJX0CS1\[D2G-QDK[6.S&LZ<+I;4WL/GG@)N&2:T*\]^)MM!9^& M;*2WB6.2.[C",HP1PW>O0(^47W%:P(3=;4V(,HAXW8Y-9GB;P6WAWQ';W- MNA;39I,H?^>;XKVKA&'4\2$*E)NFRQI.E3Z MM>K!$/EZNW917J]I;)9VL5O']R-0HJGHNCPZ19B) #(>7?NQK3KFPU#V4;O< M]G#4/9QN]SF[[PY(-=&N:7*D-\4V2HX^29??T/ YI-3T[6M#RI8W! !XZ>WRBNPP*,4_;2_0GV$#D='\/:EIWBC4=6D> MV9;XKN0$Y0#^=+9:!J4'C&[UR5K8I=1+"T8)RH&WG_QVNMHH=63U!48K0YG3 M-"O/#WVJ'2_)DM+B4S*DI(,1/4#'4<4VS\-2Z;H]]#;O'+>W[N]S-)D E@>G ML,UU-)2]I(?LHG,^#M#OO#FEKIUP\$D:LSATSG)/3%4[OPYJEQXUM?$(:U'V M>(Q"++?-PW.?^!5V5%/VLN9R[A[&/*H]$NK7Q&VNZ8\2SSQB.Y@DSM? M'0@CH>!4^HZ'Q98@27P&[[5H-)F22!+S3IQ*JG)1P,'=8UU[%GFM4- MK<"<#GMCY?TZUV5%"K26HW0B]#D_%OA_4?$NDP62O;P[)%E9B2?F&1@>W-=- M:^=]G7[0$$@ZA#D5-14.;:L7&FE+F%HHHJ2PI*6B@"M>V4%_:O;7"!XW'(-9 MVB>'X-&\QE/F2.3\Y'('85LT5+@FTWT(<(N7,UJ%+24M46%%%% !1110 444 @4 %%%% !1110 4444 %%%% !1110 4444 %%%% '_]D! end XML 7 R1.htm IDEA: XBRL DOCUMENT v3.23.3
Document and Entity Information
Nov. 09, 2023
Document And Entity Information [Line Items]  
Amendment Flag false
Entity Central Index Key 0001800682
Document Type 8-K
Document Period End Date Nov. 09, 2023
Entity Registrant Name Cano Health, Inc.
Entity File Number 001-39289
Entity Incorporation State Country Code DE
Entity Tax Identification Number 98-1524224
Entity Address, Address Line One 9725 NW 117th Avenue
Entity Address, City or Town Miami
Entity Address, State or Province FL
Entity Address, Postal Zip Code 33178
City Area Code (855)
Local Phone Number 226-6633
Written Communications false
Soliciting Material false
Pre Commencement Tender Offer false
Pre Commencement Issuer Tender Offer false
Entity Emerging Growth Company false
Common Class A [Member]  
Document And Entity Information [Line Items]  
Security 12b Title Class A common stock, $0.01 par value per share
Trading Symbol CANO
Security Exchange Name NYSE
Warrant [Member]  
Document And Entity Information [Line Items]  
Security 12b Title Warrants to purchase one share of Class A common stock, each at an exercise price of $1,150.00 per share
Trading Symbol CANO/WS
Security Exchange Name NYSE
XML 8 d798968d8k_htm.xml IDEA: XBRL DOCUMENT 0001800682 2023-11-09 2023-11-09 0001800682 us-gaap:CommonClassAMember 2023-11-09 2023-11-09 0001800682 us-gaap:WarrantMember 2023-11-09 2023-11-09 false 0001800682 8-K 2023-11-09 Cano Health, Inc. 001-39289 DE 98-1524224 9725 NW 117th Avenue Miami FL 33178 (855) 226-6633 false false false false Class A common stock, $0.01 par value per share CANO NYSE Warrants to purchase one share of Class A common stock, each at an exercise price of $1,150.00 per share CANO/WS NYSE false EXCEL 9 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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

&PO7W)E;',O M=V]R:V)O;VLN>&UL+G)E;'-02P$"% ,4 " [A6]799!YDAD! #/ P M$P @ %*$P 6T-O;G1E;G1?5'EP97-=+GAM;%!+!08 .."0 ) #X" "4% ! end XML 10 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 11 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 12 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.3 html 3 22 1 false 2 0 false 0 false false R1.htm 100000 - Document - Document and Entity Information Sheet http://www.canohealth.com//20231109/taxonomy/role/DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false All Reports Book All Reports cano-20231109.xsd cano-20231109_def.xml cano-20231109_lab.xml cano-20231109_pre.xml d798968d8k.htm g798968g1115231804429.jpg http://xbrl.sec.gov/dei/2022 true false JSON 14 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "d798968d8k.htm": { "nsprefix": "cano", "nsuri": "http://www.canohealth.com/20231109", "dts": { "schema": { "local": [ "cano-20231109.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd", "https://xbrl.sec.gov/country/2022/country-2022.xsd", "https://xbrl.sec.gov/dei/2022/dei-2022.xsd", "https://xbrl.sec.gov/naics/2022/naics-2022.xsd" ] }, "definitionLink": { "local": [ "cano-20231109_def.xml" ] }, "labelLink": { "local": [ "cano-20231109_lab.xml" ] }, "presentationLink": { "local": [ "cano-20231109_pre.xml" ] }, "inline": { "local": [ "d798968d8k.htm" ] } }, "keyStandard": 22, "keyCustom": 0, "axisStandard": 1, "axisCustom": 0, "memberStandard": 2, "memberCustom": 0, "hidden": { "total": 2, "http://xbrl.sec.gov/dei/2022": 2 }, "contextCount": 3, "entityCount": 1, "segmentCount": 2, "elementCount": 29, "unitCount": 0, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2022": 25 }, "report": { "R1": { "role": "http://www.canohealth.com//20231109/taxonomy/role/DocumentDocumentAndEntityInformation", "longName": "100000 - Document - Document and Entity Information", "shortName": "Document and Entity Information", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "duration_2023-11-09_to_2023-11-09", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "p", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d798968d8k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "duration_2023-11-09_to_2023-11-09", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "p", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d798968d8k.htm", "first": true, "unique": true } } }, "tag": { "us-gaap_StatementClassOfStockAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "StatementClassOfStockAxis", "presentation": [ "http://www.canohealth.com//20231109/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Class of Stock [Axis]", "terseLabel": "Class of Stock [Axis]" } } }, "auth_ref": [] }, "us-gaap_CommonClassAMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "CommonClassAMember", "presentation": [ "http://www.canohealth.com//20231109/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Common Class A [Member]", "terseLabel": "Common Class A [Member]" } } }, "auth_ref": [] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "WrittenCommunications", "presentation": [ "http://www.canohealth.com//20231109/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Written Communications", "terseLabel": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r6" ] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "EntityRegistrantName", "presentation": [ "http://www.canohealth.com//20231109/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r1" ] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "CityAreaCode", "presentation": [ "http://www.canohealth.com//20231109/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "City Area Code", "terseLabel": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "EntityAddressCityOrTown", "presentation": [ "http://www.canohealth.com//20231109/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://www.canohealth.com//20231109/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "EntityAddressAddressLine1", "presentation": [ "http://www.canohealth.com//20231109/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "SolicitingMaterial", "presentation": [ "http://www.canohealth.com//20231109/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Soliciting Material", "terseLabel": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r5" ] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "LocalPhoneNumber", "presentation": [ "http://www.canohealth.com//20231109/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "terseLabel": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "cano_DocumentAndEntityInformationLineItems": { "xbrltype": "stringItemType", "nsuri": "http://www.canohealth.com/20231109", "localname": "DocumentAndEntityInformationLineItems", "presentation": [ "http://www.canohealth.com//20231109/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document And Entity Information [Line Items]", "terseLabel": "Document And Entity Information [Line Items]" } } }, "auth_ref": [] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "EntityCentralIndexKey", "presentation": [ "http://www.canohealth.com//20231109/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r1" ] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "DocumentPeriodEndDate", "presentation": [ "http://www.canohealth.com//20231109/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "terseLabel": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "terseLabel": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "Security12bTitle", "presentation": [ "http://www.canohealth.com//20231109/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Security 12b Title", "terseLabel": "Security 12b Title", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r0" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://www.canohealth.com//20231109/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r1" ] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "PreCommencementTenderOffer", "presentation": [ "http://www.canohealth.com//20231109/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Pre Commencement Tender Offer", "terseLabel": "Pre Commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r4" ] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://www.canohealth.com//20231109/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Pre Commencement Issuer Tender Offer", "terseLabel": "Pre Commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r3" ] }, "us-gaap_WarrantMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "WarrantMember", "presentation": [ "http://www.canohealth.com//20231109/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Warrant [Member]", "terseLabel": "Warrant [Member]" } } }, "auth_ref": [] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "DocumentType", "presentation": [ "http://www.canohealth.com//20231109/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Type", "terseLabel": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://www.canohealth.com//20231109/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation State Country Code", "terseLabel": "Entity Incorporation State Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "AmendmentFlag", "presentation": [ "http://www.canohealth.com//20231109/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "terseLabel": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "cano_DocumentAndEntityInformationTable": { "xbrltype": "stringItemType", "nsuri": "http://www.canohealth.com/20231109", "localname": "DocumentAndEntityInformationTable", "presentation": [ "http://www.canohealth.com//20231109/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document And Entity Information [Table]", "terseLabel": "Document And Entity Information [Table]" } } }, "auth_ref": [] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "EntityFileNumber", "presentation": [ "http://www.canohealth.com//20231109/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity File Number", "terseLabel": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://www.canohealth.com//20231109/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r1" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "TradingSymbol", "presentation": [ "http://www.canohealth.com//20231109/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "terseLabel": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "us-gaap_ClassOfStockDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "ClassOfStockDomain", "presentation": [ "http://www.canohealth.com//20231109/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Class of Stock [Domain]", "terseLabel": "Class of Stock [Domain]" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://www.canohealth.com//20231109/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "SecurityExchangeName", "presentation": [ "http://www.canohealth.com//20231109/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "terseLabel": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r2" ] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Section": "14a", "Number": "240", "Subsection": "12" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" } } } ZIP 15 0001193125-23-277933-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001193125-23-277933-xbrl.zip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